Chinmaya Rath

Chinmaya Rath is an experienced executive in the biopharmaceutical industry, currently serving as the SVP and Chief Business Officer at GlycoMimetics since February 2023.1 His career spans over two decades, showcasing a diverse range of roles in pharmaceutical and biotechnology companies.

Professional Experience

Rath's journey at GlycoMimetics began in September 2022 when he joined as a Strategic Advisor before taking on his current leadership role.1 Prior to this, he held several notable positions:

Entrepreneurial and Advisory Roles::

• Founder CEO of CelluRx, a potential cell therapy spin-off
• Strategic Advisor at SalioGen Therapeutics
• Entrepreneur In Residence at Catena Biosciences

Corporate Leadership::

• Vice President of Innovation and Strategic Alliances at Omega Therapeutics
• Vice President of Strategy and Business Development at Omega Therapeutics
• Lynparza Marketing Director at AstraZeneca
• Tasigna Brand Director at Novartis

Board Positions::

• Member of the Board of Directors at Catena Biosciences
• Non-Executive Board of Director at mAbTree Biologics
• Venture Partner at Social Impact Capital

Educational Background

Rath's educational qualifications include:

• MBA from the University of Warwick - Warwick Business School, focusing on General Management with an emphasis on Finance and Strategy
• MBA in Marketing and HRM from the Army Institute of Management & Technology
• BSc in Life Sciences (Hons) from Ravenshaw University, specializing in Microbiology, Biotechnology, Biochemistry, Zoology, Botany, and Chemistry1

Chinmaya Rath's career trajectory demonstrates his expertise in business development, strategy, and leadership within the biotechnology and pharmaceutical sectors. His diverse experience across various companies and roles has likely contributed to his current position as a senior executive at GlycoMimetics.